Haleon, Dr. Reddy's Laboratories
Dr Reddy's completes acquisition of Haleon's NRT portfolio
Dr Reddy's Laboratories has acquired Haleon's global Nicotine Replacement Therapy (NRT) portfolio, excluding the US, for GBP 458 million. This includes top brands like Nicotinell, Nicabate, Thrive, and Habitrol,
Dr Reddy's completes acquisition of UK co Haleon's non-US nicotine replacement therapy biz
Hyderabad-based pharma giant Dr Reddy’s Ltd finalizes its largest acquisition by buying British Haleon Plc’s non-US nicotine replacement therapy (NRT) business for GBP 458 million. The deal includes brands like Nicotinell,
Dr. Reddy’s invests $620 mn in Swiss arm to acquire Haleon’s Nicotinell portfolio
Dr. Reddy's invests $620 million in Swiss subsidiary for acquisition of global nicotine replacement therapy brands from Haleon.
Dr. Reddy's Laboratories Completes $620-Million Investment In Switzerland Unit
The funds infused by the company into Dr. Reddy's SA will be used for the acquisition of Nicotinell and related brands.
Dr Reddy's Laboratories completes acquisition of Haleon's NRT portfolio
Dr Reddy's Laboratories on Monday said its Switzerland-based subsidiary has completed the acquisition of Haleon plc's global portfolio of consumer healthcare brands, outside of the US, in the Nicotine Replacement Therapy (NRT) category.
Dr Reddy's Acquires Haleon's NRT Portfolio
Dr Reddy's Laboratories has completed the acquisition of Haleon plc's global Nicotine Replacement Therapy (NRT) portfolio, including brands like Nicotinell, Nicabate, Thrive and Habitrol.
Business Line22h
Dr Reddy’s completes acquisition of Haleon Plc’s global portfolio of consumer healthcare brands in NRT
Dr Reddy’s Laboratories SA, Switzerland, an arm of Dr Reddy’s Laboratories, has completed the previously-announced ...
cnbctv183d
Dr Reddy’s invests $620 million in Swiss subsidiary for Nicotinell brand acquisition
Drug maker Dr Reddy's Laboratories Ltd on Friday (September 27) said it has invested $620 million in its wholly-owned ...
FiercePharma5d
Private equity firms bid on Sanofi's $16B+ consumer health business: Bloomberg
As private equity firms reportedly place their bids, Sanofi may soon follow in the footsteps of GSK and Johnson & Johnson ...
Global Nicotine Replacement Therapy Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2030 | DelveInsight
The nicotine replacement therapy market is mainly driven by increased smoking cessation programs, heightened health awareness, and the rising incidence of cancer due to ongoing tobacco use through ...
money.rediff16h
India's Current Account Deficit Widens to 1.1% of GDP
India's current account deficit widened to 1.1% of GDP in April-June 2024, driven by a rise in merchandise trade gap. The RBI ...
Dr Reddy's completes acquisition of Haleon's global NRT portfolio
DRL's Swiss subsidiary completed the acquisition through the purchase of shares of Northstar Switzerland SARL, a Haleon group ...